Home » Healthcare » Pharmaceuticals » Sterile Injectables Market

Sterile Injectables Market By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Immunoglobulin, Vaccines, Peptide Hormones, Peptide Antibiotics, Blood Factors and Others), By Therapeutic Area (Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Neurological Diseases, Musculoskeletal Diseases and Others) – Growth, Future Prospects and Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 9780 | Report Format : PDF

Market Insights

The sterile injectables market is rising with the growing demand for biologics in order to treat numerous medical conditions with immediate and effective outcomes. The increased use of injectables has transformed medical treatments because higher-quality sterile injectables have reduced the possibility of contamination or infection.

The rising prevalence of cancer and chronic diseases aided the expansion of the sterile injectables market. Surging demand for biologics and the increasing trend of biosimilars act as major growth factors for the sterile injectables market. The increased use of generic injectables in pen-filled and pre-filled syringes in medical settings has also contributed to market growth. However, low-quality injectables products, inconsistent product launches, and the recall of substandard products were a few reasons behind the global issue of a major drug shortage, which further caused severe disadvantages to patients and healthcare providers. The high cost of automation in product development in order to manufacture improved sterile injectables and stringent regulatory guidelines for product approval has created challenges for the manufacturers, which in turn have restrained market growth. The sterile injectables market is expected to grow in the future due to a focus on a broadened product portfolio with pipeline products and restructuring through mergers and acquisitions of key players.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

The scope of the research report titled “Sterile Injectables Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide investors, company executives, developers, and industry experts with detailed analysis of the market to take strategic initiatives and make business decisions regarding the prospects of the global sterile injectables market. The research report presents major market trends in the global sterile injectables market as well as the market size for the current and forecast periods. Global health concerns, increasing research expenditure, the utilization of advanced technology, and product innovation strongly boost the growth of the sterile injectables market.

This report contains an overview of the global sterile injectables market in terms of drug type, therapeutic areas, and geographical distribution. Based on drug types, the sterile injectables market is segmented into monoclonal antibodies, cytokines, insulin, immunoglobulin, vaccines, peptide hormones, peptide antibiotics, blood factors, and others. On the basis of therapeutic areas, the sterile injectables market has been classified as cancer, infectious diseases, diabetes, cardiovascular diseases, neurological diseases, musculoskeletal diseases, and others.

On the basis of geography, the sterile injectables market is classified into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, which are further categorized into major country-specific markets. The North American region consists of the data for the United States and Canada, whereas the United Kingdom, Germany, and the rest of Europe have been considered in the European region. Asia Pacific encompasses the information for China, Japan, India, and the rest of the Asia Pacific markets. Latin America is cross-sectioned into Brazil, Mexico, and other LATAM countries, and the Middle East and Africa are segmented into the GCC, South Africa, and other MEA countries. This research report provides market size and forecast for each mentioned geography from 2015 to 2025, as well as CAGRs for the forecast period from 2017 to 2025. Furthermore, the considered regional markets are further cross-sectioned on the basis of drug types and therapeutic areas.

This research study also provides insights in terms of market dynamics factors such as market drivers, restraints, and opportunities in the present and predicted markets for sterile injectables to deploy suitable business strategies. For a better understanding, the report includes comprehensive details on competitive assessment tools such as partnerships, major agreements, collaborations, mergers and acquisition activities, joint ventures, market attractiveness, and competitive landscape analysis by major players. Pfizer Inc., Mylan N.V., Baxter International Inc., Novartis AG, AstraZeneca plc., Amgen Limited, Merck & Co., Inc., Johnson & Johnson Services, Inc., Nichi-Iko Pharmaceutical Co., Sanofi, and Eli Lilly and Company are among the major players profiled in this report.

The sterile injectables market is classified on the basis of therapeutic area types, and the classes are as below:

  • Cancer
  • Infectious Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Neurological Diseases
  • Musculoskeletal Diseases
  • Others

Among all the therapeutic areas, cancer and infectious diseases are estimated to be the two most dominant segments. Sterile injectables have been shown to improve treatment outcomes in cancers such as lymphoma, cervical cancer, and testicular cancer. As per the statistics of the National Cancer Institute, there were around 14 million new cases of cancer in the year 2012, and with cancer being the world’s leading cause of death, improved measures have been taken for prevention, diagnosis, and treatment procedures among public healthcare providers. Diabetes is considered to be responsible for around 1.5 million deaths in 2012, and such a high prevalence increases the demand for sterile injectables for treatment purposes. The growing trend of chronic ailments like cardiovascular diseases and neurological diseases has also boosted the growth of the sterile injectables market as a result of benefits such as faster recovery and fewer side effects. The rising prevalence of musculoskeletal disorders causes significant health issues among workers in the United States and Europe, where sterile injectables are used for long-term relief, acting as a key driver for the sterile injectables market’s growth.

The sterile injectables market is categorized on the basis of drug types, and the categories are:

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Immunoglobulin
  • Vaccines
  • Peptide Hormones
  • Peptide Antibiotics
  • Blood Factors
  • Other Drugs

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin, owing to increasing awareness among the public and growing application areas. The key driver of the monoclonal antibody injectables market is the increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases, and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on the rise due to proper dosing frequency for any treatment, potential therapeutics, and the targeting of specific antigens. Diabetes caused 1.6 million deaths worldwide in the year 2015; such a high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop an improved healthcare system, which drives the growth of the sterile injectables market, especially vaccines. Injectable vaccines are predicted to witness lucrative growth as a result of the development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to the offered convenience. Cytokine imbalance causes multiple diseases; therefore, injectable cytokine therapy significantly conquers multiple disease progression and therefore influences the growth of the sterile injectables market.

Geographically, the global sterile injectables market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is considered to be the leading region in terms of revenue in the global sterile injectables market since the U.S. is the main outsourcing destination for sterile injectables. North America is predicted to witness steady growth owing to its developed healthcare infrastructure, the growing prevalence of cancer and diabetes, and emerging health awareness among the public. The imbalance in the demand-supply equation has affected the sterile injectables market in North America, which has opened penetration opportunities for manufacturers from other developing countries. The growth opportunity of the sterile injectables market in North America is driven by the presence of major manufacturers and their market consolidation activities. However, regulatory guidelines and stringent FDA inspections sometimes act as barriers to new product launches, which in turn restrain the growth of the sterile injectables market. The sterile injectables market in Europe is driven by improved product formulation, increasing demand, and growing contract manufacturing options.

Asia Pacific is anticipated to witness the fastest growth during the upcoming years on account of developing healthcare infrastructures, emerging economies, and a gradual growth in health awareness among the public. Market penetration of Western pharmaceutical manufacturers, changing regulatory guidelines, new product innovation, commercialization, and contract manufacturing are expected to support significant growth of the sterile injectables market in the Asia Pacific region. Growing interest among Asian manufacturers in terms of manufacturing generic injectables is expected to positively influence the global sterile injectables market.

The regional classification of the global sterile injectables market is presented as follows:

  • North America (the United States and Canada)
  • Europe (the United Kingdom, Germany, and the rest of the European countries)
  • Asia Pacific (India, Japan, China, and the rest of the Asia Pacific countries)
  • Latin America (Mexico, Brazil, and the rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa, and the rest of the MEA)

The sterile injectables market is categorized on the basis of drug types, and the categories are:

Monoclonal antibodies

  • Cytokines
  • Insulin
  • Immunoglobulin
  • Vaccines

 Peptide Hormones

 Peptide Antibiotics

  • Blood Factors
  • Other Drugs

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin, owing to increasing awareness among the public and growing application areas. The key driver of the monoclonal antibody injectables market is the increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases, and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on the rise due to proper dosing frequency for any treatment, potential therapeutics, and the targeting of specific antigens. Diabetes caused 1.6 million deaths worldwide in the year 2015; such a high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop an improved healthcare system, which drives the growth of the sterile injectables market, especially vaccines. Injectable vaccines are predicted to witness lucrative growth as a result of the development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to the offered convenience. Cytokine imbalance causes multiple diseases; therefore, injectable cytokine therapy significantly conquers multiple disease progression and therefore influences the growth of the sterile injectables market.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Sterile Injectables Market Portraiture
2.1.1. Global Sterile Injectables Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Sterile Injectables Market, by Therapeutic Area, 2016 (US$ Mn)
2.1.3. Global Sterile Injectables Market, by Geography, 2016 Vs. 2025 (Value %)

Chapter 3. Sterile Injectables Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Sterile Injectables: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Sterile Injectables Market, by Drug Type, 2016
4.2. Monoclonal Antibodies
4.3. Cytokines
4.4. Insulin
4.5. Immunoglobulin
4.6. Vaccines
4.7. Peptide Hormones
4.8. Peptide Antibiotics
4.9. Blood Factors
4.10. Others

Chapter 5. Global Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Sterile Injectables Market, by Therapeutic Area, 2016
5.2. Others Cancer
5.3. Infectious Disease
5.4. Diabetes
5.5. Cardiovascular Disease
5.6. Neurological Disease
5.7. Musculoskeletal Disease
5.8. Others

Chapter 6. Global Sterile Injectables Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Sterile Injectables Market Analysis, 2015 – 2025
6.2.1. North America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.2.3. North America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Sterile Injectables Market Analysis, 2015 – 2025
6.3.1. Europe Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.3.3. Europe Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Sterile Injectables Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Sterile Injectables Market Analysis, 2015 – 2025
6.5.1. Latin America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Sterile Injectables Market Analysis, 2015 – 2025
6.6.1. MEA Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.6.3. MEA Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. South Africa
6.6.3.3. Rest of MEA

Chapter 7. Company Profiles
7.1. Amgen Limited
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. AstraZeneca plc.
7.3. Baxter International, Inc.
7.4. Eli Lilly and Company
7.5. Johnson & Johnson Services, Inc.
7.6. Merck & Co., Inc.,
7.7. Mylan N.V.
7.8. Nichi-Iko Pharmaceutical Co.
7.9. Novartis AG
7.10. Pfizer, Inc.
7.11. Sanofi

List of Figures

FIG. 1 Sterile Injectables: Market Segmentation
FIG. 2 Global Sterile Injectables Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Sterile Injectables Market Share, by Therapeutic Area, 2016 (US$ Mn)
FIG. 4 Global Sterile Injectables Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2016
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Sterile Injectable Monoclonal Antibodies Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Sterile Injectable Cytokines Market (US$ Mn), 2015 – 2025 (US$ Mn)
FIG. 9 Global Insulin Sterile Injectable Insulin Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Sterile Injectable Immunoglobulin Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Sterile Injectable Vaccines Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Sterile Injectable Peptide Hormones Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Sterile Injectable Peptide Antibiotics Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Sterile Injectable Blood Factors Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Sterile Injectables Market for Cancer Therapy, 2015 – 2025 (US$ Mn)
FIG. 17 Global Sterile Injectables Market for Infectious Disease Treatment, 2015 – 2025 (US$ Mn)
FIG. 18 Global Sterile Injectables Market for Diabetes Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global Sterile Injectables Market for Cardiovascular Diseases Treatment, 2015 – 2025 (US$ Mn)
FIG. 20 Global Sterile Injectables Market for Neurological Diseases Treatment, 2015 – 2025 (US$ Mn)
FIG. 21 Global Sterile Injectables Market for Musculoskeletal Diseases Treatment, 2015 – 2025 (US$ Mn)
FIG. 22 Global Sterile Injectables Market for Other Therapeutic Areas, 2015 – 2025 (US$ Mn)
FIG. 23 U.S. Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 24 Canada Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 25 U.K. Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 26 Germany Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest Of Europe Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 28 Japan Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 29 China Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 30 India Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest Of Asia Pacific Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 32 Brazil Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 33 Mexico Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest Of Latin America Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 35 GCC Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 36 South Africa Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 37 Rest Of Middle East And Africa Sterile Injectables Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Sterile Injectables Market Portraiture
TABLE 2 Global Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 4 Global Sterile Injectables Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 7 North America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn
TABLE 14 Latin America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn
TABLE 17 Middle East and Africa Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Amgen Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Baxter International Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Johnson & Johnson Services, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Mylan N.V: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Nichi-Iko Pharmaceutical Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Sanofi: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage

Frequently Asked Questions:

What is the size of Sterile Injectables Market?

The market for Sterile Injectables is expected to reach US$ 324.1 Bn in 2025.

What is the Sterile Injectables Market CAGR?

The Sterile Injectables market is expected to see significant CAGR growth over the coming years,at 7.1%.

What is the Forecast period considered for Sterile Injectables Market?

The report is forecasted from 2017-2025.

What is the base year considered for Sterile Injectables Market?

The base year of this report is 2016.

Who are the major players in this Market?

Amgen Limited.,AstraZeneca plc.,Baxter International, Inc.,Eli Lilly and Company,Johnson & Johnson Services, Inc. are some of the major players in the global market.

Prostate Cancer Market

Published:
Report ID: 36273

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN